Modulators of PPAR activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.

 
Web www.patentalert.com

< Selective 3 adrenergic agonists

< Antibodies to PRO1387 polypeptides

> Secreted and transmembrane polypeptides and nucleic acids encoding the same

> Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
~ 00260